Clinical and Risk Factor Profile of Infants Treated with Bevacizumab or Nd: YAG Laser for Retinopathy of Prematurity
Salwa Khan, Sohel Mahmud, Dipak Kumer Nag, Md. Shakhawat Hossain, Sabiha Farhana Islam, Tasnuva Khan & Safinaz Khan · Ophthalmology Research: An International Journal · 2025
Background: Retinopathy of prematurity is a major cause of avoidable childhood blindness, particularly in premature infants with low birth weight and early gestational age. Both intravitreal Bevacizumab and Nd: YAG laser are established treatments for type 1 and aggressive poster...
Open access
Research Article
10.9734/or/2025/v20i4470